Prostate cancer urine test shows who needs treatment and when

Published by  News Archive

On 26th Jun 2019

Researchers at the University of East Anglia (UEA) and the Norfolk and Norwich University Hospital (NNUH) have developed a urine test to diagnose aggressive prostate cancer and predict whether patients will require treatment up to five years earlier than standard clinical methods.

The experimental new test called ‘PUR’ (Prostate Urine Risk) also identifies men who are up to eight times less likely to need treatment within five years of diagnosis.

It is hoped that the breakthrough could help large numbers of men avoid an unnecessary initial biopsy and repeated invasive follow-ups for ‘low risk’ patients on active surveillance.

Prostate cancer is the most common cancer in men in the UK. It usually develops slowly and the majority of cancers will not require treatment in a man’s lifetime. However, doctors struggle to predict which tumours will become aggressive, making it hard to decide on treatment for many men.

The most commonly used tests for prostate cancer include blood tests, a physical examination known as a digital rectal examination (DRE), an MRI scan or a biopsy.

Lead author Shea Connell from UEA’s Norwich Medical School, said: “Prostate cancer is more commonly a disease men die with rather than from. Unfortunately, we currently lack the ability to tell which men diagnosed with prostate cancer will need radical treatment and which men will not.

“Current practice assesses a patient’s disease using a PSA blood test, prostate biopsy and MRI. But up to 75 per cent of men with a raised PSA level are negative for prostate cancer on biopsy. Meanwhile 15 per cent of patients who do not have a raised PSA are found to have prostate cancer – with a further 15 per cent of these cancers being aggressive.

“A policy of ‘active surveillance’ has been developed as a way to combat this uncertainty, but it requires invasive follow-ups and constant reminders that a patient has a cancer with an uncertain natural history.”

“This results in up to 50 per cent of men on active surveillance self-electing for treatment - whether they need it or not.

“It’s clear that there is a considerable need for additional, more accurate, tests.”

The research team was led by Prof Colin Cooper, Dr Daniel Brewer and Dr Jeremy Clark, all from UEA’s Norwich Medical School, with the support and expertise of Rob Mills, Marcel Hanna and Prof Richard Ball at the NNUH.

They developed the Prostate Urine Risk (PUR) test using machine learning to look at gene expression in urine from samples collected from 537 men.

By examining the cell-free expression of 167 genes in urine samples, the team found a mathematical combination of 35 different genes that could be used to produce the PUR risk signatures.

Previous urine biomarker tests have been designed specifically for single purposes such as the detection of prostate cancer on re-biopsy (PCA3 test). But this new test uses four PUR signatures to provide a simultaneous assessment of non-cancerous tissue and risk groups (low, intermediate and high-risk) to show how aggressive the cancer is. 

Dr Clark said: “This research shows that our urine test could be used to not only diagnose prostate cancer without the need for an invasive needle biopsy but to identify a patient’s level of risk. This means that we could predict whether or not prostate cancer patients already on active surveillance would require treatment.

“The really exciting thing is that the test predicted disease progression up to five years before it was detected by standard clinical methods. 

“Furthermore, the test was able to identify men that were up to eight times less likely to need treatment within five years of diagnosis.

“If this test was to be used in the clinic, large numbers of men could avoid an unnecessary initial biopsy and the repeated, invasive follow-up of men with low-risk disease could be drastically reduced.”

Robert Mills, Consultant Surgeon in Urology at the Norfolk and Norwich University Hospital, said: “Currently diagnostic tests for prostate cancer are too non-specific to differentiate those without prostate cancer, those with low risk disease that is unlikely to be of clinical significance and those with disease that should be treated. This test has the potential to improve clinical decision making by helping to differentiate these three groups.”

Dr Mark Buzza, global director of biomedical research programs at the Movember Foundation, which funded the study, said: “The PUR test has enormous potential to transform the diagnosis and treatment of prostate cancer. We are delighted to have supported this important work under our Global Action Plan (GAP1) Biomarker project which fosters collaboration between researchers across the globe. Bringing researchers together to collaborate rather than compete for funding allows research findings to be fast-tracked for the benefit of men.”

The research was carried out in collaboration with the Norfolk and Norwich University Hospital, the Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, Emory University (US), University College Dublin, Radboud University Medical Centre (Netherlands), the University of Surrey, University College London, Queen’s University Belfast, the University of Oslo (Norway), the University of Oxford, and the Earlham Institute.

It was funded by the Movember Foundation, The Masonic Charitable Foundation, The Bob Champion Cancer Trust, the King family, the Andy Ripley Memorial Fund and the Stephen Hargrave Trust.

‘A Four‐Group Urine Risk Classifier for Predicting Outcome in Prostate Cancer Patient’ is published in the journal BJU International on Wednesday, June 26, 2019.

Latest News

  News
Businessman and businesswoman sitting face to face in a meeting
28 Sep 2020

Friendly interactions with Chinese people reduced Covid-19 prejudice

People with a history of positive social interactions with Chinese people were less likely to support discriminatory anti-Chinese policies as Covid-19 reached...

Read more >
  News
Vice Chancellor David Richardson with Covid-19 test box
28 Sep 2020

UEA launches asymptomatic Covid-19 testing for staff and students

The University of East Anglia (UEA) has today (28 September) launched in-house Covid-19 testing for its staff and students to help limit asymptomatic...

Read more >
  News
Wildfire at sunset
25 Sep 2020

New research strengthens evidence for climate change increasing risk of wildfires

A review of new scientific publications has found they strengthen the evidence that climate change increases the frequency and/or severity of fire weather in...

Read more >
Are you searching for something?
  News
Woman at her desk holding the nape of her neck
24 Sep 2020

Lockdown impact: worsening symptoms for people with bone, joint and muscle pain

People with bone, joint and muscle pain saw their symptoms worsen during lockdown – according to new research from the University of East Anglia.

Read more >
  News
Lorries queued on the M20 motorway in Kent
23 Sep 2020

No deal Brexit risks queues at the border and food shortages, new academic report finds

The most immediate and visible impact of the UK failing to get a deal with the EU will be seen at the border, with risks of queues and shortages of food, a new...

Read more >
  News
23 Sep 2020

Putting virtual rehab for stroke patients to the test

Researchers at the University of East Anglia have been putting virtual reality rehabilitation for stroke survivors to the test.

Read more >
  News
Reconstruction of the Roman Temple the Caistor team investigated
23 Sep 2020

East Anglian Studies uncovers region's rich history

Read more >
  News
Subtropical Atlantic Forest, Southern Brazil
15 Sep 2020

Study reveals impact of centuries of human activity in American tropics

The devastating effects of human activity on wildlife in the American tropics over the last 500 years are revealed in a new study published today.

Read more >
  News
Soldiers in a savannah
14 Sep 2020

Study examines how civil wars affect wildlife populations

A new study comprehensively reveals how civil wars impact wildlife in countries affected by conflict.

Read more >
  News
Union Jack and EU flag on cracked wall background

Amending Brexit deal will increase frictions within UK and beyond

The government’s decision to scrap part of its Brexit deal will increase frictions with the EU, as well as threatening the fragile political equilibrium in...

Read more >